Literature DB >> 27927824

Immunoglobulin therapy.

Sarah Louise Johnston1, Rob Hollingsworth2.   

Abstract

Immunoglobulin is an expensive blood product of potentially limited supply used in a wide variety of medical conditions, across a number of specialties. Historically, immunoglobulin has been associated with transmission of blood borne infection (eg hepatitis C). Immunoglobulin use needs to be carefully considered, appropriately prescribed and recorded. The Department of Health, in conjunction with relevant stakeholders, has established a demand management programme to secure immunoglobulin supplies for patients most in need of treatment and to limit use for indications where evidence is lacking. © Royal College of Physicians 2016. All rights reserved.

Entities:  

Keywords:  Blood product; demand management; immunoglobulin; immunomodulatory; replacement

Mesh:

Year:  2016        PMID: 27927824      PMCID: PMC6297324          DOI: 10.7861/clinmedicine.16-6-576

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  2 in total

1.  Surveillance study on the tolerability and safety of Flebogamma® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients.

Authors:  Laia Alsina; Andreas Mohr; Maria Montañés; Xènia Oliver; Esperanza Martín; Jaime Pons; Elizabeth Drewe; Jens Papke; Georg Günther; Ronnie Chee; Mark Gompels
Journal:  Pharmacol Res Perspect       Date:  2017-10

2.  Anti-CD20 treatment effectively attenuates cortical pathology in a rat model of widespread cortical demyelination.

Authors:  Michaela T Haindl; Muammer Üçal; Benjamin Klaus; Lennart Tögl; Jana Dohrmann; Milena Z Adzemovic; Christian Enzinger; Sonja Hochmeister
Journal:  J Neuroinflammation       Date:  2021-06-15       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.